Medlab International Association for the Study of Pain (IASP) 2021

International Association for the Study of Pain (IASP) 2021 virtual world congress on pain

Date of Event:   2021-06-09 - 2021-06-18
Location:  Virtual

Dr Jeremy Henson is presenting at the International Association for the Study of Pain (IASP) 2021 virtual world congress on pain (9-11 June and 16-18 June)


Abstract Title: Can improved mucosal absorption allow a THC/CBD oro-buccal spray to achieve clinical efficacy in chronic pain?


Dr Jermey discusses the results of a completed clinical study at RNSH investigating the pharmacokinetics (PK), safety, and tolerability of THC and CBD cannabinoids in a unique NanoCelle® formulation for the management of unrelieved pain in patients diagnosed with advanced cancers.

The results of the study have demonstrated acceptable bioavailability, safety, tolerability, and evidence of analgesic efficacy in advanced cancers with bone metastasis. 

Presenting an update on current research is important for those physicians who are currently prescribing medicinal cannabis for the patients where traditional therapies have failed. The level of current evidence on medicinal cannabis efficacy is low to moderate, and further research is needed for the safety of patients.


Dr. Jeremy Henson, Medical Affairs Director of Medlab
Medical Affairs Director
Dr. Jeremy Henson

Jeremy has 18 years’ experience in cancer research. He is the Principal Investigator of the Cancer Cell Immortality research group, UNSW Medicine, where his research involves the development of cancer treatments and diagnostics that target telomere maintenance mechanisms (telomerase and ALT). Jeremy discovered and patented the C-Circle biomarker and assay for the alternative-lengthening-of-telomeres (ALT) cancer mechanism (Nature Biotechnology, 2009) and is currently developing the C-Circle Assay as a cancer diagnostic and using it to perform a high-throughput screen for ALT inhibitors, which could be used as ALT-targeted cancer therapies. 

Jeremy is also Chief Career Medical officer at Lakeview Private Hospital, where he is a member of the Medical Advisory and Root Cause Analysis Committees, and a clinical tutor at Prince of Wales Clinical School, UNSW Faculty of Medicine. At Medlab, Jeremy's responsibilities include overseeing pharmacovigilance, research, clinical trials and new product development.


Tell us what you think login to share your thoughts.